These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19514326)

  • 21. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
    Drakopoulos S; Koukoulaki M; Apostolou T; Pistolas D; Balaska K; Gavriil S; Hadjiconstantinou V
    Am J Surg; 2009 Aug; 198(2):178-83. PubMed ID: 19217601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hyperphosphatemia in hemodialysis patients].
    Rieu P
    Nephrol Ther; 2005 Dec; 1 Suppl 4():S322-9. PubMed ID: 17373203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary?
    Coe FL; Canterbury J; Reiss E
    Trans Assoc Am Physicians; 1971; 84():152-61. PubMed ID: 5164300
    [No Abstract]   [Full Text] [Related]  

  • 24. Diuretics and secondary hyperparathyroidism in chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2011 Apr; 26(4):1122-5. PubMed ID: 21460359
    [No Abstract]   [Full Text] [Related]  

  • 25. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention and treatment of secondary hyperparathyroidism in CKD].
    Gueiros JE; Hernandes FR; Karohl C; Jorgetti V;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():7-14. PubMed ID: 21655856
    [No Abstract]   [Full Text] [Related]  

  • 27. The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism.
    Alfieri C; Regalia A; Zanoni F; Vettoretti S; Cozzolino M; Messa P
    Blood Purif; 2019; 47(1-3):37-44. PubMed ID: 30223271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].
    Van Overmeire L; Delanaye P; Krzesinski JM
    Rev Med Suisse; 2005 Aug; 1(30):1960-5. PubMed ID: 16200940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recurring secondary hyperparathyroidism: case report].
    Rozhinskaia LIa; Smorshchok VN; Artemova AM; Rodina LF; Makanin MA; Lapshina AM; Abrosimov AIu
    Klin Med (Mosk); 2009; 87(7):67-70. PubMed ID: 19705798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis.
    Johnson WJ; Goldsmith RS; Beabout JW; Jowsey J; Kelly PJ; Arnaud CD
    Am J Med; 1974 Jun; 56(6):827-32. PubMed ID: 4831320
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary hyperparathyroidism and pathological changes in the jaws of patients on long-term hemodialysis].
    Knezević G
    Chir Maxillofac Plast; 1984; 14(1):1-12. PubMed ID: 6594219
    [No Abstract]   [Full Text] [Related]  

  • 32. COSMOS Project: Hemodialysis scenario in Europe.
    Cannata-Andía JB; Fernández Martín JL
    Nefrologia; 2016; 36(4):381-8. PubMed ID: 27117398
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new column on calcium metabolism and its disorders].
    Houillier P; Frimat L
    Nephrol Ther; 2012 Nov; 8(6):427. PubMed ID: 23083535
    [No Abstract]   [Full Text] [Related]  

  • 34. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
    J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mineral metabolism and secondary hyperparathyroidism in celiac disease].
    Pumarino H; Campino C; Palma R; Michelsen H; Generini G
    Rev Med Chil; 1985 Nov; 113(11):1065-71. PubMed ID: 3016855
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperparathyroidism in patients on chronic hemodialysis.
    Savoy GM; Yium JJ; Jordan PH; Guinn GA
    Am J Surg; 1973 Dec; 126(6):755-7. PubMed ID: 4758794
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis.
    Wu B; Melhem M; Subramanian R; Chen P; Jaramilla Sloey B; Fouqueray B; Hock MB; Skiles GL; Chow AT; Lee E
    J Clin Pharmacol; 2018 Jun; 58(6):717-726. PubMed ID: 29534286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent secondary hyperparathyroidism.
    Ağbaht K; Güllü S
    Acta Clin Belg; 2011; 66(2):149. PubMed ID: 21630618
    [No Abstract]   [Full Text] [Related]  

  • 39. [Parathyroid carcinoma associated to secondary hyperparathyroidism in hemodialyzed patients. Two cases reports].
    Fuster D; Torregrosa JV; Esteve V; Ybarra J; Sabater L; Alós L; Fernández-Cruz L; Campistol JM
    Nefrologia; 2007; 27(2):209-13. PubMed ID: 17564567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A common cause of pruritus in dialysis patients.
    Jenkins P
    Am J Kidney Dis; 2008 Feb; 51(2):345; author reply 345-6. PubMed ID: 18215714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.